Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120006) titled 'Itraconazole for treating reactive skin capillary hyperplasia induced by camrelizumab: A single-arm study' on March 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Affiliated Hospital of Guangdong Medical College
Condition:
Reactive cutane-ous capillary endothelial proliferation
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-03-07
Target Sample Size: Treatment Group:14;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308720
Disclaimer: Curated by HT Syndication....